Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Current assets:    
Cash and cash equivalents $ 179,338 $ 141,666
Accounts receivable 60,587 96,043
Inventories 14,643 15,161
Deferred tax assets, net 0 1,264
Income tax receivable, net 5,651 0
Prepaid expenses and other current assets 12,896 9,213
Total current assets 273,115 263,347
Property, plant and equipment, net 264,240 241,764
In-process research and development 41,800 41,800
Intangible assets, net 30,148 0
Goodwill 13,954 5,502
Deferred tax assets, net 0 11,087
Other assets 3,373 730
Total assets 626,630 564,230
Current liabilities:    
Accounts payable 27,521 31,297
Accrued expenses and other current liabilities 1,252 1,488
Accrued compensation 24,615 22,726
Contingent purchase consideration, current portion 1,341 0
Income tax payable, net 0 115
Deferred tax liability, net 88 0
Long-term indebtedness, current portion 0 4,470
Deferred revenue 1,834 1,811
Total current liabilities 56,651 61,907
Contingent purchase consideraton, net of current portion 15,278 0
Long-term indebtedness, net of current portion 62,000 58,304
Deferred tax liability, net 1,419 0
Other liabilities 2,117 1,891
Total liabilities 137,465 122,102
Commitments and contingencies      
Stockholders' equity:    
Preferred stock, $0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at December 31, 2013 and December 31, 2012, respectively 0 0
Common stock, $0.001 par value; 100,000,000 shares authorized, 37,036,996 shares issued and 36,624,043 shares outstanding at December 31, 2013; 36,272,550 shares issued and 35,869,392 outstanding at December 31, 2012 37 36
Treasury stock, at cost, 412,953 and 403,158 common shares at December 31, 2013 and 2012, respectively (6,119) (5,906)
Additional paid-in capital 247,637 230,964
Accumulated other comprehensive loss (3,465) (4,129)
Retained earnings 251,528 220,393
Total Emergent BioSolutions Inc. stockholders' equity 489,618 441,358
Noncontrolling interest in subsidiaries (453) 770
Total stockholders' equity 489,165 442,128
Total liabilities and stockholders' equity $ 626,630 $ 564,230